Ribonucleic Acid News and Research

RSS

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

In a new study, researchers performed genomic sequencing of SARS-CoV-2-infected samples and aimed to identify the dominant variant, assess the mutation profile, and determine the sample-to-sequence turnover time.

1 Mar 2022

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

In a new study, researchers developed and elucidated a ‘bridge integration’ method to harmonize single-cell ribonucleic acid sequencing datasets.

1 Mar 2022

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

In a new study, researchers used deep transcriptome analysis to examine the coding and non-coding transcriptional landscape of lung cells infected with SARS-CoV-2.

1 Mar 2022

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

In a new study, researchers evaluated the immune responses induced by the mRNA-based SARS-CoV-2 vaccination against SARS-CoV-2 variants in multiple myeloma patients.

1 Mar 2022

A study on the evolution of avian coronavirus escape mutants in vitro

A recent study included an in vitro assessment of the effect of antibody titers and vaccine combinations on the emergence of escape mutants of AvCoV.

28 Feb 2022

Study compares heterologous and homologous third vaccination in kidney transplant recipients

A new study assesses the comparative neutralizing antibody level elicited by three mRNA vaccine doses to a heterologous COVID-19 vaccine regimen.

28 Feb 2022

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

A recent study evaluated the molecular and histopathological effects in the placenta following a SARS-CoV-2 infection during pregnancy.

28 Feb 2022

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

In a recent study, researchers evaluated the effect of COVID-19 vaccines on the symptomatic prevalence of SARS-CoV-2 infections beyond the acute phase of the disease.

28 Feb 2022

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

The team analyzed the effect of sampling frequency on the prediction error of IRs by using reduced sampling across different sewer sheds of varying sizes and features.

28 Feb 2022

Health events amongst pregnant females after COVID-19 vaccination

Researchers evidenced that mRNA-based COVID-19 vaccines are safe in pregnancy, with lower rates of significant AEFIs in pregnant women than non-pregnant females.

28 Feb 2022

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Researchers emphasized the need to take on a holistic and unbiased approach to develop a universal vaccine for coronaviruses, including SARS-CoV-2, which is a biomedical priority during the ongoing COVID-19 pandemic.

28 Feb 2022

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

A new study discusses the emergence of new variants of SARS-CoV-2 that can escape antibody-mediated neutralization, as opposed to other Sarbecoviruses.

27 Feb 2022

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

A new study discusses changes in the microbiota of various parts of the body with SARS-CoV-2 infection.

27 Feb 2022

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Researchers evaluated the efficacy of SARS-CoV-2 vaccines made by Pfizer, Jansen, and Moderna against symptomatic and asymptomatic COVID-19 cases.

25 Feb 2022

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Researchers characterized humoral and SARS-CoV-2 S-specific T cell responses in IBD patients who received two-dose mRNA-based COVID-19 vaccination series.

25 Feb 2022

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Researchers evaluated CMIR in IBD patients following immunization with two doses of COVID-19 vaccine.

25 Feb 2022

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Researchers assess the serological response to a real-world COVID-19 vaccination strategy in older individuals who resided in long-term care facilities.

24 Feb 2022

A comparison of COVID-19 vaccines by neutralizing antibody potency

Researchers use an international standardized assessment method to compare the efficacy of antibody responses to the major COVID-19 vaccines.

24 Feb 2022

Third dose of mRNA-based COVID-19 vaccine efficiently recalls Omicron-reactive B cell memory

A new study examined how the quantity and quality of antibody and memory B cell responses to SARS-CoV-2 change temporally and with the number of exposures to antigens.

24 Feb 2022

Ribonucleic Acid News and Research

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Study explores dictionary learning-based bridge integration method for data harmonization of single-cell analysis

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

A study on the evolution of avian coronavirus escape mutants in vitro

Study compares heterologous and homologous third vaccination in kidney transplant recipients

Breakthrough SARS-CoV-2 infection peaks at 5 months

Histopathologic and molecular effects in the placenta after SARS-CoV-2 infection during pregnancy

Study finds lower prevalence of post-acute SARS-CoV-2 symptomology in vaccinated individuals

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Health events amongst pregnant females after COVID-19 vaccination

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Cell-mediated immune response among inflammatory bowel disease patients after mRNA COVID-19 vaccination

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

A comparison of COVID-19 vaccines by neutralizing antibody potency

Third dose of mRNA-based COVID-19 vaccine efficiently recalls Omicron-reactive B cell memory

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News